LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 39

Search options

  1. Article: Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF).

    Huchet, Noémie / Penel, Nicolas / Bonvalot, Sylvie / Thariat, Juliette / Ducimetière, Françoise / Giraud, Antoine / Toulmonde, Maud / Le Cesne, Axel / Blay, Jean-Yves / Bellera, Carine

    Therapeutic advances in medical oncology

    2024  Volume 16, Page(s) 17588359231220999

    Abstract: Background: Missing covariates are common in observational research and can lead to bias and loss of statistical power. Limited data regarding prognostic factors of survival outcomes of sarcomas in irradiated fields (SIF) are available. Because of the ... ...

    Abstract Background: Missing covariates are common in observational research and can lead to bias and loss of statistical power. Limited data regarding prognostic factors of survival outcomes of sarcomas in irradiated fields (SIF) are available. Because of the long lag time between irradiation of first cancer and scarcity of SIF, missing data are a critical issue when analyzing long-term outcomes. We assessed prognostic factors of overall (OS), progression-free (PFS), and metastatic-progression-free (MPFS) survivals in SIF using three methods to account for missing covariates.
    Methods: We relied on the NETSARC French Sarcoma Group database, Cox (OS/PFS), and competitive hazards (MPFS) survival models. Covariates investigated were age, sex, histological subtype, tumor size, depth and grade, metastasis, surgery, surgical resection, surgeon's expertise, imaging, and neo-adjuvant treatment. We first applied multiple imputation (MI): observed data were used to estimate the missing covariate. With the missing-data modality approach, a category missing was created for qualitative variables. With the complete-case (CC) approach, analysis was restricted to patients without missing covariates.
    Results: CC subjects (
    Conclusion: The CC population was not representative of the eligible population, introducing bias, in addition to worst precision. The 'missing-data modality method' results in biased estimates in non-randomized studies, as outcomes may be related to variables with missing values. Appropriate statistical methods for missing covariates, for example, MI, should therefore be considered.
    Language English
    Publishing date 2024-01-19
    Publishing country England
    Document type Journal Article
    ZDB-ID 2503443-1
    ISSN 1758-8359 ; 1758-8340
    ISSN (online) 1758-8359
    ISSN 1758-8340
    DOI 10.1177/17588359231220999
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison.

    Penel, Nicolas / Cantarel, Coralie / Chemin-Airiau, Claire / Ducimetiere, Françoise / Gouin, François / Le Loarer, François / Toulmonde, Maud / Piperno-Neumann, Sophie / Bellera, Carine / Honore, Charles / Blay, Jean-Yves / Mathoulin-Pelissier, Simone

    Therapeutic advances in medical oncology

    2023  Volume 15, Page(s) 17588359231192400

    Abstract: Background: The coronavirus disease 2019 (COVID-19) pandemic was an unprecedented shock to the healthcare systems, and its consequences on managing rare cancers are unknown. We investigated COVID-19's impact on the activity of sarcoma-labeled networks ... ...

    Abstract Background: The coronavirus disease 2019 (COVID-19) pandemic was an unprecedented shock to the healthcare systems, and its consequences on managing rare cancers are unknown. We investigated COVID-19's impact on the activity of sarcoma-labeled networks by comparing key indicators in 2019-2020 (before and during the pandemic, respectively).
    Methods: We compared the incidence of limb and trunk soft tissue sarcomas, surgery rate, surgery center, surgery quality, and surgery delays nationally and in various regions, focusing on the three most severely affected regions.
    Findings: In this study, sarcoma incidence did not decrease, and the tumor and patient characteristics were similar in both years. The number of patients who underwent surgery in the labeled centers increased significantly (63%
    Interpretation: The model of the labeled center network for managing rare tumors was resilient. Paradoxically, the quality indicators improved during the pandemic due to the direct referral of patients with sarcomas to the labeled centers.
    Summary: This study shows that a nationwide network organization has made it possible to maintain care for these rare tumors during the pandemic.
    Language English
    Publishing date 2023-08-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 2503443-1
    ISSN 1758-8359 ; 1758-8340
    ISSN (online) 1758-8359
    ISSN 1758-8340
    DOI 10.1177/17588359231192400
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Correction to: Beyond the map: evidencing the spatial dimension of health inequalities.

    Fayet, Yohan / Praud, Delphine / Fervers, Béatrice / Ray-Coquard, Isabelle / Blay, Jean-Yves / Ducimetiere, Françoise / Fagherazzi, Guy / Faure, Elodie

    International journal of health geographics

    2021  Volume 20, Issue 1, Page(s) 1

    Language English
    Publishing date 2021-01-04
    Publishing country England
    Document type Published Erratum
    ISSN 1476-072X
    ISSN (online) 1476-072X
    DOI 10.1186/s12942-020-00255-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Beyond the map

    Fayet Yohan / Praud Delphine / Fervers Béatrice / Ray-Coquard Isabelle / Blay Jean-Yves / Ducimetiere Françoise / Fagherazzi Guy / Faure Elodie

    International Journal of Health Geographics, Vol 19, Iss 1, Pp 1-

    evidencing the spatial dimension of health inequalities

    2020  Volume 11

    Abstract: Abstract Background Spatial inequalities in health result from different exposures to health risk factors according to the features of geographical contexts, in terms of physical environment, social deprivation, and health care accessibility. Using a ... ...

    Abstract Abstract Background Spatial inequalities in health result from different exposures to health risk factors according to the features of geographical contexts, in terms of physical environment, social deprivation, and health care accessibility. Using a common geographical referential, which combines indices measuring these contextual features, could improve the comparability of studies and the understanding of the spatial dimension of health inequalities. Methods We developed the Geographical Classification for Health studies (GeoClasH) to distinguish French municipalities according to their ability to influence health outcomes. Ten contextual scores measuring physical and social environment as well as spatial accessibility of health care have been computed and combined to classify French municipalities through a K-means clustering. Age-standardized mortality rates according to the clusters of this classification have been calculated to assess its effectiveness. Results Significant lower mortality rates compared to the mainland France population were found in the Wealthy Metropolitan Areas (SMR = 0.868, 95% CI 0.863–0.873) and in the Residential Outskirts (SMR = 0.971, 95% CI 0.964–0.978), while significant excess mortality were found for Precarious Population Districts (SMR = 1.037, 95% CI 1.035–1.039), Agricultural and Industrial Plains (SMR = 1.066, 95% CI 1.063–1.070) and Rural Margins (SMR = 1.042, 95% CI 1.037–1.047). Conclusions Our results evidence the comprehensive contribution of the geographical context in the constitution of health inequalities. To our knowledge, GeoClasH is the first nationwide classification that combines social, environmental and health care access scores at the municipality scale. It can therefore be used as a proxy to assess the geographical context of the individuals in public health studies.
    Keywords Health inequalities ; Environment ; Social deprivation ; Health care access ; Geography ; Public health ; Computer applications to medicine. Medical informatics ; R858-859.7
    Subject code 910
    Language English
    Publishing date 2020-11-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune Microenvironment.

    Feng, Xiaolan / Tonon, Laurie / Li, Haocheng / Darbo, Elodie / Pleasance, Erin / Macagno, Nicolas / Dufresne, Armelle / Brahmi, Mehdi / Bollard, Julien / Ducimetière, Francoise / Karanian, Marie / Meurgey, Alexandra / Pérot, Gaëlle / Valentin, Thibaud / Chibon, Frédéric / Blay, Jean-Yves

    Cancers

    2023  Volume 15, Issue 14

    Abstract: Purpose: ...

    Abstract Purpose:
    Language English
    Publishing date 2023-07-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15143705
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study.

    Chvetzoff, Gisele / Girodet, Magali / Despax, Johanna / Baudry, Valentine / Duranti, Julie / Mastroianni, Bénédicte / Vanacker, Hélène / Vinceneux, Armelle / Brahmi, Mehdi / Renard, Olivier / Gautier, Julien / Britel, Manon / Ducimetière, Françoise / Anota, Amélie / Cassier, Philippe / Christophe, Véronique

    BMJ open

    2022  Volume 12, Issue 4, Page(s) e060317

    Abstract: Introduction: A few studies have highlighted the potential synergy between early palliative care and inclusion in an early-phase clinical trial that may improve quality of life, reduce symptoms of exhaustion related to the side effects of treatment and ... ...

    Abstract Introduction: A few studies have highlighted the potential synergy between early palliative care and inclusion in an early-phase clinical trial that may improve quality of life, reduce symptoms of exhaustion related to the side effects of treatment and allow patients to complete their treatment protocol. The primary objective of this qualitative study is to evaluate the reasons for acceptance or refusal of early palliative care in patients included in early-phase clinical trials.
    Method and analysis: All patients from the Centre Léon Bérard (Comprehensive Cancer Centre in Lyon, France) who consent to one of the early-phase clinical trials proposed at the centre will be invited to participate in this study. The cohort will consist of a subgroup (n=20) of patients who accept palliative care together with their clinical trial, and a second subgroup (n=20) of patients who decline it. Patients will be interviewed in exploratory interviews conducted by a psychology researcher before the start of their clinical trial. The interviews will be audio-recorded. Patients will also be asked to complete quality of life and anxiety/depression questionnaires both before the beginning of the treatment and at the end of their clinical trial. The content of the interviews will be analysed thematically. Descriptive and comparative statistical analysis of both cohorts will also be conducted.
    Ethics and dissemination: Personal data will be collected and processed in accordance with the laws and regulations in force. All patients will give informed consent to participate. This study complies with reference methodology MR004 of the Commission Nationale de l'Informatique et des Libertés. The protocol has received the validation of an ethics committee (Groupe de Réflexion Ethique du CLB, number: 2020-006). The results will be disseminated through conference presentations and peer-reviewed publications.
    Trial registration number: NCT04717440.
    MeSH term(s) France ; Hospice and Palliative Care Nursing ; Humans ; Neoplasms/therapy ; Palliative Care ; Qualitative Research ; Quality of Life
    Language English
    Publishing date 2022-04-22
    Publishing country England
    Document type Clinical Study ; Journal Article
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2021-060317
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene Loss.

    Feng, Xiaolan / Li, Haocheng / Fourquet, Joanna / Brahmi, Mehdi / Dufresne, Armelle / Meurgey, Alexandra / Ray-Coquard, Isabelle / Wang, Qing / Bollard, Julien / Ducimetiere, Francoise / Chibon, Frederic / Blay, Jean-Yves

    JCO precision oncology

    2022  Volume 6, Page(s) e2200129

    Abstract: Purpose: To investigate the use of PTEN biomarker to improve prognostic stratification in patients with localized gastrointestinal stromal tumor (GIST).: Methods: PTEN expression and genomic analysis were performed on two independent GIST-60 (n = 60) ...

    Abstract Purpose: To investigate the use of PTEN biomarker to improve prognostic stratification in patients with localized gastrointestinal stromal tumor (GIST).
    Methods: PTEN expression and genomic analysis were performed on two independent GIST-60 (n = 60) and GIST-100 (n = 100) cohorts, respectively.
    Results: PTEN expression was significantly lower in patients with local and metastatic recurrent tumor compared with those with no recurrence (
    Conclusion: PTEN low expression/gene loss is an independent significant prognostic factor and a promising component to strengthen the clinical prognostic tools in patients with localized GIST.
    MeSH term(s) Disease-Free Survival ; Gastrointestinal Neoplasms/genetics ; Gastrointestinal Stromal Tumors/genetics ; Humans ; Prognosis ; Tensins
    Chemical Substances Tensins
    Language English
    Publishing date 2022-08-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2473-4284
    ISSN (online) 2473-4284
    DOI 10.1200/PO.22.00129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Beyond the map: evidencing the spatial dimension of health inequalities.

    Fayet, Yohan / Praud, Delphine / Fervers, Béatrice / Ray-Coquard, Isabelle / Blay, Jean-Yves / Ducimetiere, Françoise / Fagherazzi, Guy / Faure, Elodie

    International journal of health geographics

    2020  Volume 19, Issue 1, Page(s) 46

    Abstract: Background: Spatial inequalities in health result from different exposures to health risk factors according to the features of geographical contexts, in terms of physical environment, social deprivation, and health care accessibility. Using a common ... ...

    Abstract Background: Spatial inequalities in health result from different exposures to health risk factors according to the features of geographical contexts, in terms of physical environment, social deprivation, and health care accessibility. Using a common geographical referential, which combines indices measuring these contextual features, could improve the comparability of studies and the understanding of the spatial dimension of health inequalities.
    Methods: We developed the Geographical Classification for Health studies (GeoClasH) to distinguish French municipalities according to their ability to influence health outcomes. Ten contextual scores measuring physical and social environment as well as spatial accessibility of health care have been computed and combined to classify French municipalities through a K-means clustering. Age-standardized mortality rates according to the clusters of this classification have been calculated to assess its effectiveness.
    Results: Significant lower mortality rates compared to the mainland France population were found in the Wealthy Metropolitan Areas (SMR = 0.868, 95% CI 0.863-0.873) and in the Residential Outskirts (SMR = 0.971, 95% CI 0.964-0.978), while significant excess mortality were found for Precarious Population Districts (SMR = 1.037, 95% CI 1.035-1.039), Agricultural and Industrial Plains (SMR = 1.066, 95% CI 1.063-1.070) and Rural Margins (SMR = 1.042, 95% CI 1.037-1.047).
    Conclusions: Our results evidence the comprehensive contribution of the geographical context in the constitution of health inequalities. To our knowledge, GeoClasH is the first nationwide classification that combines social, environmental and health care access scores at the municipality scale. It can therefore be used as a proxy to assess the geographical context of the individuals in public health studies.
    MeSH term(s) Cities ; France/epidemiology ; Health Status Disparities ; Humans ; Risk Factors ; Rural Population ; Socioeconomic Factors
    Language English
    Publishing date 2020-11-09
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1476-072X
    ISSN (online) 1476-072X
    DOI 10.1186/s12942-020-00242-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The value of research collaborations and consortia in rare cancers.

    Blay, Jean-Yves / Coindre, Jean-Michel / Ducimetière, Françoise / Ray-Coquard, Isabelle

    The Lancet. Oncology

    2016  Volume 17, Issue 2, Page(s) e62–e69

    Abstract: Rare cancers are defined by an incidence of less than six per 100,000 people per year. They represent roughly 20% of all human cancers and are associated with worse survival than are so-called frequent tumours, because of delays to accurate diagnosis, ... ...

    Abstract Rare cancers are defined by an incidence of less than six per 100,000 people per year. They represent roughly 20% of all human cancers and are associated with worse survival than are so-called frequent tumours, because of delays to accurate diagnosis, inadequate treatments, and fewer opportunities to participate in clinical trials (because of a paucity of dedicated trials from both academic and industrial sponsors). In this Series paper, we discuss how these challenges can be addressed by research consortia and suggest the integration of these consortia with reference networks, which gather multidisciplinary expert centres, for management of rare tumours.
    MeSH term(s) Biomedical Research/organization & administration ; Clinical Trials as Topic/legislation & jurisprudence ; Clinical Trials as Topic/methods ; Communication ; Cooperative Behavior ; Drug Industry ; Humans ; Neoplasms/diagnosis ; Neoplasms/therapy ; Patient Advocacy ; Rare Diseases/diagnosis ; Rare Diseases/therapy ; Translational Medical Research
    Language English
    Publishing date 2016-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2049730-1
    ISSN 1474-5488 ; 1470-2045
    ISSN (online) 1474-5488
    ISSN 1470-2045
    DOI 10.1016/S1470-2045(15)00388-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades.

    Toulmonde, Maud / Dinart, Derek / Brahmi, Mehdi / Verret, Benjamin / Jean-Denis, Myriam / Ducimetière, Françoise / Desolneux, Gregoire / Méeus, Pierre / Palussière, Jean / Buy, Xavier / Bouhamama, Amine / Gillon, Pauline / Dufresne, Armelle / Hénon, Clémence / Le Loarer, François / Karanian, Marie / Ngo, Carine / Mathoulin-Pélissier, Simone / Bellera, Carine /
    Le Cesne, Axel / Blay, Jean Yves / Italiano, Antoine

    Cancers

    2023  Volume 15, Issue 17

    Abstract: Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors characterized ... ...

    Abstract Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors characterized by
    Language English
    Publishing date 2023-08-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15174306
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top